✓ checked
trust me, bro:
here is the receipt.
the claim
Prostate cancer often develops very slowly and does not cause problems for the patient.
the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against
Is it true that prostate cancer often develops very slowly and does not cause problems for the patient?
Yes. Prostate cancer frequently exhibits slow growth and an indolent natural history, leading to active surveillance protocols to prevent unnecessary treatment for low-risk disease.
Verdict: SUPPORTED · 5 sources for, 0 against · Last checked
The analysis
The retrieved literature consistently confirms that prostate cancer often progresses very slowly, remaining indolent and non-threatening for many patients, which supports the claim.
Evidence for · 5
Identifies gene signatures to specifically detect indolent prostate cancer to prevent overtreatment.
Get citation
TA, G., S, T., KH, S., CJ, S., RT, L., EN, W., M, L., MJ, S., KL, P., G, P., & LA, M. (2026). A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer.. doi.org. https://doi.org/10.1002/pros.70189
See more details
More for · 4
Demonstrates that prostate cancer typically grows very slowly, taking many years to reach clinical detectability.
Get citation
H, S., V, S., F, G., CM, M., B, N., M, E., PDP, P., & N, P. (2026). Variation in prostate cancer growth rates in an MRI-based active surveillance cohort.. doi.org. https://doi.org/10.1007/s00330-025-12248-y
Confirms through long-term reviews that low-grade prostate cancer often remains indolent for 15-20 years.
Get citation
AK, T., R, M., P, W., M, D., SA, K., & AE, T. (2026). Natural history of untreated prostate cancer: a comprehensive review of long-term progression patterns and survival outcomes.. doi.org. https://doi.org/10.1038/s41391-026-01095-7
Notes that many men diagnosed with early prostate cancer do not require immediate treatment and can be safely managed.
Get citation
K, S., S, P., DS, B., & VJ, G. (2026). Mechanisms of Progression and Challenges for Intervention in the Natural History of Early Prostate Cancer: A Narrative Review.. doi.org. https://doi.org/10.3390/curroncol33060370
Highlights that standard screening often detects indolent lesions that may not cause clinical harm.
Get citation
L, L., L, Z., Z, L., K, C., & W, R. (2026). Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review).. doi.org. https://doi.org/10.3892/mmr.2026.13954
What does the evidence say?
The retrieved literature consistently confirms that prostate cancer often progresses very slowly, remaining indolent and non-threatening for many patients, which supports the claim.
Receipt History
Anyone with this link can read the claim and its public receipt, including any
personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check
or guarantee a response time.
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work
Terms · Privacy · How verdicts work